METTL3 and gastric cancer: Similarly, miR-4429, another potential therapeutic target in gastric cancer (GC), targets and downregulates METTL3 to inhibit m6A-induced stabilization of SEC62, which in turn inhibits cell proliferation and induces apoptosis in GC cells [91].